Biotech2050’s Post

View organization page for Biotech2050, graphic

3,725 followers

Excited to have Praveen Tipirneni, CEO of Morphic Therapeutic, join us on the latest episode! With a focus on developing transformative treatments for autoimmune diseases, Morphic Therapeutic is making significant strides in the biotech industry. In this episode hosted by Rahul Chaturvedi, Founder and CEO of Clora, Praveen shares insights into the current state of autoimmune therapies and Morphic's innovative approaches, including their pioneering work on oral integrin inhibitors. He also discusses his extensive experience in corporate development and strategy, highlighting the importance of building strong teams and fostering a culture of excellence. Tune in for an insightful discussion on the future of autoimmune treatment and the role of Morphic Therapeutic in shaping it! Listen now: https://lnkd.in/g6ftzSDt #Biotech #AutoimmuneTherapies #Innovation #Leadership #Healthcare #Podcast #Biotech2050

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics